Research
Hormonal
Leptin-replacement therapy reduces liver volume and improves liver function tests in patients with lipodystrophy.
Leptin therapy shrinks enlarged livers and improves liver enzymes in patients with lipodystrophy, reducing the risk of liver disease.
GoodSupportsHIGH confidence
Four months of therapy decreased average triglyceride levels by 60 percent... and liver volume by an average of 28 percent... in all nine patients
Why this rating
Small sample size but statistically significant results.
Source
Leptin-Replacement Therapy for Lipodystrophy
Elif A Oral et al. · New England Journal of Medicine · 2002
DOI 10.1056/nejmoa012437
clinical_trial · n=9Cited 1,233×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →